News + Filings Transactions
|
Brennan Aoife
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/09/2023 | FIBROGEN INC | FGEN | Sale | Common Stock | 2.7k | $17.52 | $48k | | 06/07/2023 |
| 06/09/2023 | FIBROGEN INC | FGEN | Sale | Common Stock | 2k | $16.74 | $33.4k | | 06/07/2023 |
| 06/07/2023 | FIBROGEN INC | FGEN | Grant | Common Stock | 8.3k | $0.00 | $0 | | 06/07/2023 |
| 06/07/2023 | FIBROGEN INC | FGEN | Grant | Stock Option (Right to Buy) | 12.7k | $17.13 | $217k | | 06/07/2023 |
| 04/03/2023 | SYNLOGIC, INC. | SYBX | Sale | Common Stock | 19k | $0.58 | $11k | | 04/03/2023 |
| 06/16/2022 | FIBROGEN INC | FGEN | Grant | Stock Option (Right to Buy) | 25.7k | $9.00 | $231.2k | | 06/16/2022 |
| 06/16/2022 | FIBROGEN INC | FGEN | Grant | Common Stock | 15.8k | $0.00 | $0 | | 06/16/2022 |
| 04/04/2022 | SYNLOGIC, INC. | SYBX | Sale | Common Stock | 8.9k | $2.45 | $21.8k | | 04/04/2022 |
| 02/04/2022 | SYNLOGIC, INC. | SYBX | Grant | Common Stock | 106.9k | $0.00 | $0 | | 02/04/2022 |
| 02/04/2022 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 434.2k | $1.95 | $846.6k | | 02/04/2022 |
| 05/26/2021 | FIBROGEN INC | FGEN | Grant | Stock Option (Right to Buy) | 7.8k | $20.86 | $162.7k | | 05/26/2021 |
| 05/26/2021 | FIBROGEN INC | FGEN | Grant | Common Stock | 4.7k | $0.00 | $0 | | 05/26/2021 |
| 03/10/2021 | SYNLOGIC, INC. | SYBX | Grant | Common Stock | 71.2k | $0.00 | $0 | | 03/10/2021 |
| 03/10/2021 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 285k | $3.50 | $997.5k | | 03/10/2021 |
| 08/05/2020 | FIBROGEN INC | FGEN | Grant | Stock Option (Right to Buy) | 10.4k | $42.65 | $443.6k | | 08/05/2020 |
| 08/05/2020 | FIBROGEN INC | FGEN | Grant | Common Stock | 3.9k | $0.00 | $0 | | 08/05/2020 |
| 08/05/2020 | FIBROGEN INC | FGEN | Grant | Stock Option (Right to Buy) | 6.5k | $42.65 | $277.1k | | 08/05/2020 |
| 04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 15k | $19.88 | $298.2k | | 04/02/2020 |
| 04/02/2020 | Ra Pharmaceuticals, Inc. | RARX | Disposition | Stock Option (Right to Buy) | 25k | $16.36 | $409k | | 04/02/2020 |
| 03/10/2020 | SYNLOGIC, INC. | SYBX | Grant | Common Stock | 46.3k | $0.00 | $0 | | 03/10/2020 |
| 03/10/2020 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 185.3k | $1.70 | $315k | | 03/10/2020 |
| 09/23/2019 | SYNLOGIC, INC. | SYBX | Grant | Common Stock | 8k | $0.00 | $0 | | 09/23/2019 |
| 06/11/2019 | Ra Pharmaceuticals, Inc. | RARX | Grant | Option to Purchase Common Stock | 15k | $19.88 | $298.2k | | 06/11/2019 |
| 03/05/2019 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 185k | $8.59 | $1.6M | | 03/05/2019 |
| 10/31/2018 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 150k | $7.91 | $1.2M | | 10/31/2018 |
| 09/21/2018 | Ra Pharmaceuticals, Inc. | RARX | Grant | Options to Purchase Common Stock | 25k | $16.36 | $409k | | 09/21/2018 |
| 06/05/2018 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 54k | $9.55 | $515.7k | | 06/05/2018 |
| 03/14/2018 | SYNLOGIC, INC. | SYBX | Grant | Stock Option (right to buy) | 56k | $9.95 | $557.2k | | 03/14/2018 |
|